Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

被引:0
作者
Shahin Akhondzadeh
Raofeh Ghayyoumi
Farzin Rezaei
Bahman Salehi
Amir-Hossein Modabbernia
Azad Maroufi
Gholam-Reza Esfandiari
Mehrangiz Naderi
Fariba Ghebleh
Mina Tabrizi
Shams-Ali Rezazadeh
机构
[1] Tehran University of Medical Sciences,Psychiatric Research Center, Roozbeh Psychiatric Hospital
[2] Kurdistan University of Medical Sciences,Qods Hospital
[3] Arak University of Medical Sciences,Shaheed Hashemi Senejani Hospital
[4] Tehran University of Medical Sciences,Department of Medical Genetics, Faculty of Medicine
[5] Institute of Medicinal Plants (ACECR),undefined
来源
Psychopharmacology | 2011年 / 213卷
关键词
Adjunctive therapy; Sildenafil; Negative symptoms; Schizophrenia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:809 / 815
页数:6
相关论文
共 79 条
[1]  
Abbasi SH(2010)The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial Schizophr Res 116 101-106
[2]  
Behpournia H(1998)The glutamate hypothesis of schizophrenia J Clin Pharm Ther 23 243-246
[3]  
Ghoreshi A(2001)The 5-HT hypothesis of schizophrenia IDrugs 4 295-300
[4]  
Salehi B(2006)Pharmacotherapy of schizophrenia: the past, present and future Curr Drug Ther 1 1-7
[5]  
Raznahan M(1999)Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study J Clin Pharm Ther 24 49-42
[6]  
Rezazadeh SA(2006)Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia Schizophr Res 84 405-410
[7]  
Rezaei F(2007)Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial Schizophr Res 90 179-185
[8]  
Akhondzadeh S(2007)Persistent negative symptoms in schizophrenia: an overview Schizophr Bull 33 1013-1022
[9]  
Akhondzadeh S(2007)Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? Acta Psychiatr Scand 115 93-100
[10]  
Akhondzadeh S(2004)Schizophrenia: from dopamine to glutamate and back Curr Med Chem 11 267-277